Suppr超能文献

Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.

作者信息

Bérubé D, Vallée F, Panneton A C, Bergeron M G, LeBel M

机构信息

Ecole de Pharmacie, Université Laval, Quebec, Canada.

出版信息

Antimicrob Agents Chemother. 1988 Mar;32(3):354-7. doi: 10.1128/AAC.32.3.354.

Abstract

The pharmacokinetics of carumonam after single and multiple intravenous administration of 1- and 2-g dosage regimens were studied in 12 young male volunteers. Plasma and urine samples were collected in serial order for 24 h and assayed by high-pressure liquid chromatography. The mean elimination half-life of carumonam was not significantly affected by either dosage regimen or single dose versus steady state, ranging from 1.3 to 1.5 h. Mean concentrations at the end of the interval were not influenced by a multiple-dose administration. The normalized volume of distribution was independent of the dose, with values ranging from 0.16 to 0.19 liters/kg. After multiple administration, carumonam was cleared from the body more rapidly: from 96.2 to 121.7 ml/min after 1 g every 8 h, and from 102.1 to 122.3 ml/min after 2 g every 8 h (P less than 0.05). After 24 h, 75.0 to 80.7% of the dose was excreted unchanged in the urine. The protein binding of carumonam to human plasma remained stable at 28%. Carumonam was well tolerated by the volunteers.

摘要

相似文献

1
Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.
Antimicrob Agents Chemother. 1988 Mar;32(3):354-7. doi: 10.1128/AAC.32.3.354.
2
Multiple intravenous dose pharmacokinetic study of carumonam in healthy subjects.
J Antimicrob Chemother. 1989 Jan;23(1):107-11. doi: 10.1093/jac/23.1.107.
3
Pharmacokinetics of carumonam in patients with renal insufficiency.
Antimicrob Agents Chemother. 1986 Jan;29(1):116-21. doi: 10.1128/AAC.29.1.116.
4
Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
Antimicrob Agents Chemother. 1985 Sep;28(3):425-7. doi: 10.1128/AAC.28.3.425.
5
Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
Antimicrob Agents Chemother. 1986 Jun;29(6):1017-24. doi: 10.1128/AAC.29.6.1017.
6
Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
Antimicrob Agents Chemother. 1986 Jan;29(1):127-34. doi: 10.1128/AAC.29.1.127.
7
Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.
Diagn Microbiol Infect Dis. 2009 Oct;65(2):130-41. doi: 10.1016/j.diagmicrobio.2009.06.018.
9
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Antimicrob Agents Chemother. 1988 Apr;32(4):473-6. doi: 10.1128/AAC.32.4.473.

引用本文的文献

1
Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
Antimicrob Agents Chemother. 1991 Jun;35(6):1048-52. doi: 10.1128/AAC.35.6.1048.

本文引用的文献

5
Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
Antimicrob Agents Chemother. 1983 Jan;23(1):125-32. doi: 10.1128/AAC.23.1.125.
6
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
Antimicrob Agents Chemother. 1984 Dec;26(6):898-902. doi: 10.1128/AAC.26.6.898.
7
Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
Antimicrob Agents Chemother. 1985 Sep;28(3):425-7. doi: 10.1128/AAC.28.3.425.
10
Pharmacokinetics of carumonam in patients with renal insufficiency.
Antimicrob Agents Chemother. 1986 Jan;29(1):116-21. doi: 10.1128/AAC.29.1.116.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验